Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a new version of the ClinicalTrials.gov record. This reflects an internal update to the page rather than changes to study details or results.
    Difference
    0.1%
    Check dated 2026-08-08T18:19:25.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, signaling a new release of the page template or tooling; there are no visible content changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T10:46:32.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page’s revision tag changed from v3.6.2 to v3.6.3. This reflects a deployment/version update rather than a change to the page content.
    Difference
    0.1%
    Check dated 2026-07-03T22:00:02.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.2, replacing the previous v3.6.0. This indicates a newer revision of the page content and related materials.
    Difference
    0.1%
    Check dated 2026-06-26T23:46:11.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the recruitment status to No longer looking for participants, indicating no current enrollment. A header formatting change and a revision label update are also present.
    Difference
    0.5%
    Check dated 2026-06-12T13:47:03.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.5.4 to v3.5.5, signaling a minor page-level update. No study content, eligibility criteria, or results information appear to have changed.
    Difference
    0.1%
    Check dated 2026-06-05T10:16:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.